Skip to main content
SpringerLink
Log in

Die Bedeutung von lokalen Gutachterkommissionen (Institutional Review Boards) für den Schutz der Versuchsperson

  • Chapter
Psychiatrische Therapie-Forschung

Part of the book series: Monographien aus dem Gesamtgebiete der Psychiatrie ((PSYCHIATRIE,volume 19))

  • 19 Accesses

Zusammenfassung

Obwohl man seit langem erkannt hat, daß für jegliche Art der medizinischen Behandlung die Einwilligung des Patienten eingeholt werden sollte, sei es zur Therapie oder für die Forschung, gibt es viele Beispiele, wo dieses Dictum nicht erfüllt wurde. In Amerika hat die Sorge um den Schutz der Versuchspersonen in der klinischen Forschung eine Reihe von Bundesvorschriften hervorgebracht. Eine der wichtigsten dieser Vorschriften, vom „Department of Health, Education, and Weifare” von 1966 (1), fordert die Einrichtung von lokalen Gutachter-Kommissionen, um die Rechte und die Gesundheit der Versuchspersonen zu schützen, die an öffentlich unterstützten Forschungsaktivitäten der jeweüigen Institutionen (wie z.B. Krankenhäuser oder Kliniken) teilnehmen. Das Ziel der folgenden Ausführungen ist es, die allgemeine Bedeutung der neuesten Bundesvorschriften sowie die Rolle der lokalen Gutachterkommissionen für den Schutz von Versuchspersonen, die an klinischer Forschung teilnehmen, darzustellen.

Übersetzung aus dem Englischen: B. Müller-Oerlinghausen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. U.S. Public Health Service: Policy and Procedure Order No. 129, July 1, 1966

    Google Scholar 

  2. Taylor, W.J.R.: Introduction. In: Peer Review in Human Research, F.G. McMahon (ed.). Mount Kisco, N.Y.: Futura Publishing, in press

    Google Scholar 

  3. Hodges, R.M.: Ethical Considerations in Clinical Research. In: Principles and Techniques of Human Research and Therapeutics. Volume 1: General Considerations and Principles. McMahon, F.G. (ed.). Mount Kisco, N.Y.: Futura Publishing 1974

    Google Scholar 

  4. Percival, Sir Thomas: Medical Ethics. Manchester, England: J. Johnson 1803

    Google Scholar 

  5. Office of the Adjutant General of the United States: Trials of War Criminals. U.S. Government Printing Office, Washington, D.C., Vol. 2, pp. 181–183, 1947

    Google Scholar 

  6. World Medical Assembly: Declaration of Helsinki. Helsinki 1964

    Google Scholar 

  7. World Health Assembly: Declaration of Tokyo. Tokyo 1975

    Google Scholar 

  8. World Psychiatric Association: Declaration of Hawaii. Hawaii 1977

    Google Scholar 

  9. Kefauver-Harris Amendments of October 10, 1962 to the Food, Drugs and Cosmetic Act; Code of Federal Regulations; U.S. Government Printing Office, Washington, D.C., 1962

    Google Scholar 

  10. National Academy of Sciences/National Research Council: Final Report, Drug Efficacy Study. U.S. Government Printing Office, Food and Drug Administration Publication. Washington, D.C., July 9, 1969

    Google Scholar 

  11. Smith, Kline and French Laboratories: A Chronology and Review of the National Academy of Sciences/National Research Council Drug Efficacy Study: A Monograph. Smith, Kline and French Laboratories; Philadelphia, Pa., March 1971

    Google Scholar 

  12. Fortner vs. Koch: Northwestern Reports, 261, 762 (1935)

    Google Scholar 

  13. Chalkley, D.T.: The NIH Role in the Support and Regulation of Clinical Research. In: Principles and Techniques of Human Research and Therapeutics, Volume 1: General Considerations and Principles, McMahon, F.G. (ed.). Mount Kisco, N.Y.: Futura Publishing 1974

    Google Scholar 

  14. Beecher, H.K.: Research and the Individual. Boston, Mass.: Little, Brown and Co. 1970

    Google Scholar 

  15. The National Research, Training and Protection of Human Research Subjects Act, Public Law 93–348. (CR 120, H5727–32, June 28, 1974)

    Google Scholar 

  16. Federal Register, May 30, 1974 (39 FR 18914)

    Google Scholar 

  17. Survey Research Center, Institute for Social Research, University of Michigan: Research Involving Human Subjects: A Report to the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. University of Michigan; Ann Arbor, Mich., October 2, 1976

    Google Scholar 

  18. CFR 310.102

    Google Scholar 

  19. Lisook, A.B.: Responsibilities of Clinical Investigators — FDA Viewpoint. In: Principles and Techniques of Human Research and Therapeutics, Volume 1: General Considerations and Principles, McMahon, F.G. (ed.). Mpunt Kisco, N.Y.: Futura Publishing 1974

    Google Scholar 

  20. Federal Register, April 17, 1971

    Google Scholar 

  21. Department of Health, Education and Welfare: The Institutional Guide to DHEW Policy on Protection of Human Rights. U.S. Government Printing Office, DHEW Publication 72–102; Washington, D.C., 1971

    Google Scholar 

  22. Department of Health, Education and Welfare; DHEW Grants Administration Manual, Chapter 1–40. U.S. Government Printing Office, DHEW Publication; Washington, D.C.

    Google Scholar 

  23. University of Pennsylvania Office of Research Administration: Human Beings in Research, a Manual Describing Policies and Procedures. University of Pennsylvania; Philadelphia, Pa., 1974

    Google Scholar 

  24. Public Responsibility in Medicine and Research Conference on the Protection of Human Subjects and the Role of Institutional Review Boards. Held in Boston, Mass.: April 16–17, 1977

    Google Scholar 

  25. Melmon, K.L.: The clinical pharmacologist and scientifically unsound regulations for drug development. Clin. Pharmacol, and Therapeutics 20 (2), 125–129 (1976)

    CAS  Google Scholar 

  26. Robins, L.N.: Problems in follow-up studies. Am. J. Psychiatry 134, 8 (1977)

    Google Scholar 

  27. American Public Health Association Conference on Ethical Issues in Adolescent Health. Held in Washington, D.C.: December 6–7, 1976

    Google Scholar 

  28. Hirsch, B.D.: Hie medico-legal framework for clinical research in medicine. Ann. N.Y. Acad, of Science 169, 308 (1970)

    Article  Google Scholar 

  29. Mahoney, M.J.: Ethical considerations in fetal research. Conn. Medicine 41 (2), 85–89 (1977)

    CAS  Google Scholar 

  30. Pilon, J.G.: Cost-benefit ethics and fetal research. Human Life Review 3 (1), 63–70 (1977)

    PubMed  Google Scholar 

  31. Roth, L.H., et al.: Tests of competency to consent to treatment. Am. J. Psychiatry 134, 3 (1977)

    Google Scholar 

  32. McGough, L.S., Carmichael, W.C.: The right to treatment and the right to refuse treatment. Am. J. Orthopsychiatry 47 (2), 307–320 (1977)

    Article  PubMed  CAS  Google Scholar 

  33. Robitscher, J.: The right to psychiatric treatment: a socio-legal approach to the plight of the state hospital patient. Villanova Law Rev. 18, 11–36 (1972)

    Google Scholar 

  34. Helmchen, H., Müller-Oerlinghausen, B.: The inherent paradox of clinical trials in psychiatry. J. Med. Ethics. 1, 168–173 (1975)

    Article  PubMed  CAS  Google Scholar 

  35. Helmchen, H., Müller, Oerlinghausen, B.: Ethische und juristische Schwierigkeiten bei der Effizienzprüfung psychiatrischer Therapieverfahren. Nervenarzt 46, 397–403

    Google Scholar 

  36. Varley, A.B.: The Legal Environment and Clinical Research. In: Principles and Techniques of Human Research and Therapeutics, Volume 1: General Considerations and Principles, McMahon, F.G. (ed.). Mount Kisco, N.Y.: Futura Publishing 1974

    Google Scholar 

  37. Frank, J.: Courts on Trial. Princeton, N.J.: Princeton University Press 1950

    Google Scholar 

  38. Cole, J.O.: Research barriers in psychopharmacology. Am. J. Psychiatry 134, 8 (1977)

    Google Scholar 

  39. Barber, B., et al.: Research on Human Subjects: Problems of Social Control in Medical Experimentation. Russell Sage Foundation, New York, 1973

    Google Scholar 

  40. Gray, B.H.: An assessment of institutional review committees in human experimentation. Medical Care 13 (4), 318–328 (1975)

    Article  PubMed  CAS  Google Scholar 

  41. Gray, B.H.: The functions of human subjects review committees. Am. J. Psychiatry 134, 8 (1977)

    Google Scholar 

  42. Hassar, M., Weintraub, M.: „Uninformed” consent and the healthy volunteer: An analysis of patient volunteers in a clinical trial of a new anti-inflammatory drug. Clin. Pharmacol, and Therapeutics 20 (4), 379–386 (1976)

    CAS  Google Scholar 

  43. Ingelfinger, F.J.: Informed (but uneducated) consent. New Engl. J. Med. 287, 465–466(1972)

    Article  PubMed  CAS  Google Scholar 

  44. Laforet, E.G.: The fiction of informed consent. J. Am. Med. Ass. 235, 1579–1585

    Google Scholar 

  45. Sackler, A.M.: Informed consent. Medical tribune 15, 23 (1974)

    Google Scholar 

  46. Rickeis, K. (ed.): Non-Specific Factors in Drug Therapy. Springfield, I11.: Charles C Thomas 1968

    Google Scholar 

  47. Chalkley, D.T.: Federal constraints: Earned or unearned? Am. J. Psychiatry 134, 911–913 (1977)

    PubMed  CAS  Google Scholar 

  48. Laves, B.S.: Legal aspects of experimentation with institutionalized mentally disabled subjects. J. of Clin. Pharmacology 16, 592–599 (1976)

    Article  CAS  Google Scholar 

  49. Orne, M.T., Evans, F.J.: Social control in the psychological experiment: Antisocial behavior and hypnosis. J. of Personality and Social Psychology 1, 189–200 (1965)

    Article  Google Scholar 

Download references

Authors
  1. K. Rickels
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik, Freien Universität Berlin, Nußbaumallee 36, D-1000, Berlin 19, Deutschland

    H. Helmchen  & B. Müller-Oerlinghausen  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Rickels, K. (1978). Die Bedeutung von lokalen Gutachterkommissionen (Institutional Review Boards) für den Schutz der Versuchsperson. In: Helmchen, H., Müller-Oerlinghausen, B. (eds) Psychiatrische Therapie-Forschung. Monographien aus dem Gesamtgebiete der Psychiatrie, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87982-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-87982-1_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-87983-8

  • Online ISBN: 978-3-642-87982-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation